China Anti-Cancer Association guideline for diagnosis and treatment of cancer of multiple and unknown primaries (2023 edition) [PDF]
Cancer of unknown primary (CUP) and cancer of multiple primaries (CMP) are two groups of neoplasm with high heterogeneity, low incidence, limited clinical knowledge and evidence.
Society of Cancer of Multiple and Unknown Primary of China Anti-Cancer Association Yuguang
doaj +2 more sources
Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition) [PDF]
Oxaliplatin serves as a basic therapeutic agent for various malignant tumors. Oxaliplatin-induced hypersensitivity reactions are potentially life-threatening, and frequently lead to treatment discontinuation.
Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association
doaj +1 more source
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition) [PDF]
Colorectal cancer is a common malignant tumor in China. At present, the incidence rate and the mortality rate of colorectal cancer in China are on the rise.
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association
doaj +3 more sources
Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition) [PDF]
In China, 60% of breast cancer patients were premenopausal women at the time of diagnosis. Compared with postmenopausal women, premenopausal women have strong ovarian function and secrete estrogen to promote breast cancer growth.
China Anti-Cancer Association Committee of Breast Cancer Society,
doaj +2 more sources
Expert consensus on perioperative comprehensive treatment for high risk prostate cancer (2023 edition) [PDF]
The incidence rate of prostate cancer is showing an upward trend year by year, gradually becoming an important disease affecting the health of middle-aged and elderly men.
of Male Reproductive System Oncology Society +1 more
doaj +2 more sources
A novel, cancer-fighting function was recently discovered for Smad ubiquitination regulatory factor 2 (Smurf2).
Zhao Keji, Shi Yun-Bo
openaire +3 more sources
EGFR-TKI ADR Management Chinese Expert Consensus
ErbB receptor tyrosine kinase inhibitors (EGFR-TKI), gefitinib, erlotinib, icotinib and aftinib, which are approved as a frontline treatment for patients with non-small cell lung cancer (NSCLC) who have tumors harboring EGFR mutations in China.
Chinese Society of Lung Cancer, Chinese Anti-Cancer Association
doaj +1 more source
The Anti-Cancer Effects of Frondoside A [PDF]
Frondoside A is a triterpenoid glycoside from the Atlantic Sea Cucumber, Cucumaria frondosa. Frondoside A has a broad spectrum of anti-cancer effects, including induction of cellular apoptosis, inhibition of cancer cell growth, migration, invasion, formation of metastases, and angiogenesis.
Thomas E. Adrian, Peter Collin
openaire +3 more sources
Which is the Prognostic Value of the Mini Mental State Examination Test in Surgical Oncology? [PDF]
Introduction: Cancer patients are usually subjected to numerous surgeries during their course of treatment. Recent studies suggest that anesthetic drugs such as propofol, benzodiazepines, and opioids are linked to cognitive impairment.Aim: The aim of the
Alexandrina Nikova +6 more
doaj +3 more sources
Shanghai expert consensus on whole-process management of antineoplastic-induced nausea and vomiting (2024 edition) [PDF]
Nausea and vomiting are common adverse reactions in tumor patients during anti-tumor therapy such as chemotherapy, radiotherapy, targeted therapy and immunotherapy.
Cancer Rehabilitation and Palliative Professional Committee of Shanghai Anti-Cancer Association +2 more
doaj +2 more sources

